In a study by Jesse K. Mckenney regarding the role of IHC in the diagnosis of bladder neoplasms, the incidence of various markers in bladder and prostate cancers was investigated that PSA in prostate cancer was positive in about 68-94%, but there was no positive in any of the cases of bladder cancer. This evidence concerns the gene KLK3 and urinary bladder cancer.